ImmunoScape is a pre-clinical biotechnology company focused on the discovery and development of next-generation TCR cell therapies in the field of oncology. The company's proprietary Deep Immunomics technology platform enables highly sensitive, large-scale mining and immune profiling of T cells in cancer patient samples to identify novel, therapeutically relevant TCRs across multiple types of solid tumors. ImmunoScape has multiple discovery programs ongoing and will be progressing towards IND-enabling studies and entry into the clinic.
To learn more, visit us at immunoscape.com and follow us on Twitter @immunoscape.
Company Details
- Employees
- 30
- Founded
- -
- Address
- 1 Scotts Road, Singapore,singapore
- in****@****ape.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- immunoscape.com
- Keywords
- immunotherapy, mass cytometry, immunomonitoring, T cell antigens, oncology, infectious diseases, autoimmune diseases, cytographer, Immunoprofiling, CyTOF, neoantigen, biomarker, vaccine.
- HQ
- Singapore
Immunoscape Questions
Immunoscape's website is immunoscape.com
Immunoscape's LinkedIn profile is https://www.linkedin.com/company/immunoscape
Immunoscape has
30 employees.
View email and phone details for 30
employees at Immunoscape.
Immunoscape's industry is
Biotechnology Research
Immunoscape's top competitors are
Aum Biosciences,
Engine Biosciences,
Hummingbird Bioscience,
Nsg Biolabs,
Tikva Allocell Pte Ltd,
Lucence,
Nuevocor,
Allozymes,
Tessa Therapeutics Ltd,
Mirxes.
Immunoscape's support email address is info@immunoscape.com
Immunoscape's categories are Biotechnology Research
Immunoscape's founding year is 2016
